Stock & Company Details
BriaCell Therapeutics Corp $BCTX
Price:
N/A
N/A
8.7M
$30M
52 Week High:
N/A
10 Day Average Volume:
N/A
-0.19
50 Day Moving Average:
N/A
52 Week Low:
N/A
30 Day Average Volume:
N/A
N/A
N/A
N/A
30 Day Change:
N/A
3 Month Change:
N/A
Health Technology
BCTX technical indicators
Latest BriaCell Therapeutics Corp (BCTX) indicator readings as of 2026-10-29.
BCTX's 14-day RSI is 37.2, in neutral territory. At $3.31 it is trading 13.4% below its 200-day moving average of $3.82, and below its 50-day average of $3.79. Price sits near the lower Bollinger Band ($3.17 to $4.20). ADX reads 27.5, indicating a trending market.
Overview
BriaCell Therapeutics Corp is an immuno-oncology-focused biotechnology company. The group develops targeted and safe approaches for the management of cancer. BriaCell is conducting a Phase I/IIa clinical trial of Bria-IMT in metastatic breast cancer. Additionally, it is developing Bria-OTS, off-the-shelf personalized immunotherapy, for the treatment of advance-stage breast cancer by matching the patient's HLA type.
Finance Bot
Ask your questions
Start by typing a question below.
